The Minister of Health of the Republic of Latvia
"...Today we can be proud that Rigvir is not only our success story, but at the same
time it is a real help and hope for cancer patients not only in Latvia, but all around
"...In the sixties of the last century Latvian scientists proved the ability of viruses to fight malignant tumours by adapting specific virus that was named Rigvir (Riga virus). In next decades, scientists worked actively to prove effectiveness of the virus in various preclinical and clinical trials both in Latvia and in the rest of the world. In 2004 Rigvir was registered as a cancer-treating medicine and in 2005 the Latvian Academy of Sciences acknowledged Rigvir as one of the greatest inventions in Latvia..."
Professor, Dr. habil. chem. Ivars Kalvins,
European Academy of Sciencies and Arts(Zalcburg),
Corresponding Member, Latvian Academy of Sciences,
Director of Latvian Institute of Organic Synthesis: www.osi.lv,
author of Mildronate and Leakadine,
author of 550 publications, including patents,
Certificate and Golden Medal of World Intellectual Property Organisation (WIPO) for
long-term and highly productive work as an inventor.
“…Cancer virotherapy is one of the most promising modern cancer therapy methods. Therefore, the leading countries in the development of pharmaceutical products have largely involved in virological researches with the aim of finding the most effective and safest viruses with the ability to selectively destroy malignant cells. Nobody doubts any more that viruses are able to do it. Just like nobody doubts any more that Latvia through Rigvir has become the leader and, at the same time, the pioneer in virotherapy. The only question is – how much time will it take until some other viral anticancer medicines will join Rigvir. Clearer and stronger with every day, virotherapy is claimed around the world as one of the firm primary therapy types, that can be more effective, safer, and patient-caring than the cancer treatment methods known until now…”
Director at Latvian tourism development agency
"...Latvia is able to offer highly qualified medical staff and services on European level at considerably lower prices than in other countries of the European Union. Latvia has become the world leader in the sphere of virotherapy. Aiming at further virotherapy development in October, 2008, Latvia's leading scientists – immunologists and oncologists – established Latvian Virotherapy Center. Owing to many years of studies and unique scientific discoveries, Latvia offers the use of Rigvir virus that is for now the only virus in the world which has passed the full cycle of clinical trials and is able to destroy malignant tumours, possessing, at the same time, unique immunoactivating properties..."full article